US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 5.100
  • +0.910+21.72%
Close Aug 9 16:00 ET
  • 4.990
  • -0.110-2.16%
Post 20:01 ET
303.05MMarket Cap-7968P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aldeyra Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.28

-86.67%
Analyst Rating

Strong Buy

Aug 6, 2024

Aldeyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 16.667M--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 1.000M--
--2023/Q40.000 / 2.429M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 16.667M--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 1.000M--
--2023/Q40.000 / 2.429M--

Unlock Free Earnings Estimates

Aldeyra Therapeutics Earnings Reports

  • Aldeyra Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:10 ET

  • Aldeyra Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 2 16:10 ET

  • Aldeyra Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 16:10 ET

  • Aldeyra Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 6, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-4.29%